MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $8.2 million in its third quarter.

On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 31 cents.

The medical device company focused on psychiatric disorders posted revenue of $13.8 million in the period.

Neuronetics expects full-year revenue in the range of $53.3 million to $54.3 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News